Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock

SARASCHANDRA VALLABHAJOSYULA; ANTHONY J. FAUGNO; BORUI LI; KEVIN JOHN; QIUYUE KONG; SHASHANK S. SINHA; JAIME HERNANDEZ-MONTFORT; MANREET K. KANWAR; JACOB ABRAHAM; VANESSA BLUMER; MARYJANE FARR; JUSTIN FRIED; ARTHUR R. GARAN; SHELLEY HALL; GAVIN W. HICKEY; RACHNA KATARIA; J. U. KIM; S. O.N.G. LI; CLAUDIUS MAHR; SANDEEP NATHAN; MOHIT PAHUJA; PAAVNI SANGAL; ANDREW SCHWARTZMAN; VAN A.N.K.H.U.E. TON; OLEG A. VISHNEVSKY; ESTHER VOROVICH; KAROL D. WALEC; PETER ZAZZALI; ELRIC ZWECK; DANIEL BURKHOFF; NAVIN K. KAPUR

Journal Article

Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock

Journal of Cardiac Failure (2024) 30(11) 1516-1521

DOI: 10.1016/j.cardfail.2024.06.010

10Citations

6Readers

Get full text

Author supplied keywords

Cite

CITATION STYLE

APA

VALLABHAJOSYULA, S., FAUGNO, A. J., LI, B., JOHN, K., KONG, Q., SINHA, S. S., … KAPUR, N. K. (2024). Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock. Journal of Cardiac Failure, 30(11), 1516–1521. https://doi.org/10.1016/j.cardfail.2024.06.010

Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock

Author supplied keywords

Cite

Register to see more suggestions